Usability evaluation of sufentanil sublingual tablet analgesia in patients following Enhanced Recovery After Surgery

J Comp Eff Res. 2021 Jun;10(9):743-750. doi: 10.2217/cer-2020-0239. Epub 2021 Apr 21.

Abstract

Aim: To evaluate the usability and satisfaction from the sufentanil sublingual tablet system analgesia in the Enhanced Recovery After Surgery pathway in patients, nurses and physical therapist. Materials & methods: A system usability scale was used to evaluate analgesia system in the prospective observational study in spine, orthopedic and thoracic patients. Result: In 111 cases the median system usability scale score was 90 (80-100) (patients) and 72.5 (57.5-82.5) (nurses). The median satisfaction score of the physiotherapist was 90 (75-100). Conclusion: The usability and the satisfaction of the patients and the caregivers from sufentanil sublingual tablet system analgesia in the context of Enhanced Recovery After Surgery protocol were good-to-excellent. The economic potential in the reduction of hospital stay should be studied. Trial registration number: NCT03373851 (ClinicalTrial.gov).

Keywords: enhanced recovery after surgery; satisfaction; sufentanil sublingual tablet system; usability.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Sublingual
  • Analgesia, Patient-Controlled
  • Analgesics, Opioid
  • Enhanced Recovery After Surgery*
  • Humans
  • Pain, Postoperative / drug therapy
  • Sufentanil* / therapeutic use
  • Tablets / therapeutic use

Substances

  • Analgesics, Opioid
  • Tablets
  • Sufentanil

Associated data

  • ClinicalTrials.gov/NCT03373851

Grants and funding